Resveratrol/Selenium Nanocomposite with Antioxidative and Antibacterial Properties.

Nina Tomić, Magdalena M Stevanović, Nenad Filipović, Tea Ganić, Biljana Nikolić, Ina Gajić, Dragana Mitić Ćulafić
Author Information
  1. Nina Tomić: Group for Biomedical Engineering and Nanobiotechnology, Institute of Technical Sciences of SASA, Kneza Mihaila 35/IV, 11000 Belgrade, Serbia. ORCID
  2. Magdalena M Stevanović: Group for Biomedical Engineering and Nanobiotechnology, Institute of Technical Sciences of SASA, Kneza Mihaila 35/IV, 11000 Belgrade, Serbia. ORCID
  3. Nenad Filipović: Group for Biomedical Engineering and Nanobiotechnology, Institute of Technical Sciences of SASA, Kneza Mihaila 35/IV, 11000 Belgrade, Serbia. ORCID
  4. Tea Ganić: Faculty of Biology, University of Belgrade, Studentski trg 16, 11000 Belgrade, Serbia.
  5. Biljana Nikolić: Faculty of Biology, University of Belgrade, Studentski trg 16, 11000 Belgrade, Serbia. ORCID
  6. Ina Gajić: Faculty of Medicine, Institute of Microbiology and Immunology, University of Belgrade, 11000 Belgrade, Serbia. ORCID
  7. Dragana Mitić Ćulafić: Faculty of Biology, University of Belgrade, Studentski trg 16, 11000 Belgrade, Serbia. ORCID

Abstract

In this work, we synthesized a new composite material comprised of previously formulated resveratrol nanobelt-like particles (ResNPs) and selenium nanoparticles (SeNPs), namely ResSeNPs. Characterization was provided by FESEM and optical microscopy, as well as by UV-Vis and FTIR spectroscopy, the last showing hydrogen bonds between ResNPs and SeNPs. DPPH, TBA, and FRAP assays showed excellent antioxidative abilities with ResNPs and SeNPs contributing mainly to lipid peroxidation inhibition and reducing/scavenging activity, respectively. The antibacterial effect against common medicinal implant colonizers pointed to notably higher activity against isolates (minimal inhibitory concentrations 0.75-1.5%) compared to tested gram-negative species ( and ). Antibiofilm activity against , , and determined in a crystal violet assay was promising (up to 69%), but monitoring of selected biofilm-related gene expression (A and D) indicated the necessity of the involvement of a larger number of genes in the analysis in order to further establish the underlying mechanism. Although biocompatibility screening showed some cytotoxicity and genotoxicity in MTT and alkaline comet assays, respectively, it is important to note that active antioxidative and antibacterial/antibiofilm concentrations were non-cytotoxic and non-genotoxic in normal MRC-5 cells. These results encourage further composite improvements and investigation in order to adapt it for specific biomedical purposes.

Keywords

References

  1. Int J Nanomedicine. 2018 Apr 10;13:2107-2128 [PMID: 29692609]
  2. J Biomater Appl. 2014 Feb 12;29(2):303-317 [PMID: 24522241]
  3. Int J Oncol. 2020 Oct;57(4):925-938 [PMID: 32945383]
  4. J Hosp Infect. 2018 Feb;98(2):111-117 [PMID: 29175074]
  5. J Biomed Mater Res A. 2018 Dec;106(12):3034-3041 [PMID: 30295993]
  6. J Biomater Appl. 2023 Jul;38(1):122-133 [PMID: 37303075]
  7. Int J Mol Sci. 2018 Mar 09;19(3): [PMID: 29522491]
  8. J Fluoresc. 2008 May-Jul;18(3-4):671-8 [PMID: 18351302]
  9. Food Chem Toxicol. 2011 Sep;49(9):2035-45 [PMID: 21620923]
  10. Evid Based Complement Alternat Med. 2021 Mar 16;2021:8866311 [PMID: 33815561]
  11. Nutrients. 2019 Jul 31;11(8): [PMID: 31370365]
  12. Food Chem Toxicol. 2009 Jan;47(1):260-6 [PMID: 19049815]
  13. Acta Biomater. 2021 Jan 1;119:57-74 [PMID: 33166714]
  14. Biomater Sci. 2022 Aug 9;10(16):4392-4423 [PMID: 35796210]
  15. Front Bioeng Biotechnol. 2021 Jan 25;8:624621 [PMID: 33569376]
  16. Nat Rev Microbiol. 2018 Jul;16(7):397-409 [PMID: 29720707]
  17. Int J Antimicrob Agents. 2019 Jun;53(6):716-723 [PMID: 30825504]
  18. Nutrients. 2021 May 13;13(5): [PMID: 34068374]
  19. BMC Complement Altern Med. 2017 Oct 4;17(1):477 [PMID: 28978315]
  20. Molecules. 2021 Jun 12;26(12): [PMID: 34204666]
  21. Adv Healthc Mater. 2021 Aug;10(16):e2100598 [PMID: 34121366]
  22. Foods. 2021 Feb 17;10(2): [PMID: 33671296]
  23. Nanoscale Res Lett. 2015 Dec;10(1):1051 [PMID: 26334544]
  24. PLoS One. 2013 Nov 08;8(11):e81132 [PMID: 24260549]
  25. J Bacteriol. 2013 May;195(10):2329-39 [PMID: 23504011]
  26. Front Mol Biosci. 2021 Sep 01;8:649395 [PMID: 34540888]
  27. Nature. 2005 Aug 25;436(7054):1171-5 [PMID: 16121184]
  28. Iran J Microbiol. 2020 Dec;12(6):565-576 [PMID: 33613911]
  29. Nanomaterials (Basel). 2023 Jul 29;13(15): [PMID: 37570523]
  30. Antibiotics (Basel). 2023 May 31;12(6): [PMID: 37370304]
  31. ACS Nano. 2023 Jan 10;17(1):168-183 [PMID: 36524981]
  32. Nanomaterials (Basel). 2022 May 29;12(11): [PMID: 35683711]
  33. ACS Omega. 2020 Feb 05;5(6):2660-2669 [PMID: 32095689]
  34. Tissue Eng Part B Rev. 2022 Jun;28(3):633-664 [PMID: 34210148]
  35. Cancers (Basel). 2021 Jan 07;13(2): [PMID: 33430318]
  36. Saudi Pharm J. 2013 Apr;21(2):143-52 [PMID: 24936134]
  37. J Phys Chem B. 2010 Mar 11;114(9):3348-54 [PMID: 20148537]
  38. Bull Exp Biol Med. 2019 Oct;167(6):763-766 [PMID: 31655997]
  39. Biotechnol Appl Biochem. 2018 May;65(3):419-427 [PMID: 28968917]
  40. Adv Appl Bioinform Chem. 2021 Jan 14;14:1-11 [PMID: 33488102]
  41. BMC Res Notes. 2020 Jan 10;13(1):27 [PMID: 31924268]